Stockscreener 앱 받기
3.17
2.16%
-0.07
시간 외 거래:
3.18
0.01
+0.32%
전일 마감가:
$3.24
열려 있는:
$3.25
하루 거래량:
516.31K
Relative Volume:
0.13
시가총액:
$36.16M
수익:
$32.77M
순이익/손실:
$-101.98M
주가수익비율:
-0.3299
EPS:
-9.6101
순현금흐름:
$-112.43M
1주 성능:
-2.76%
1개월 성능:
+8.19%
6개월 성능:
-64.73%
1년 성능:
-85.07%
1일 변동 폭
$3.01
$3.42
1주일 범위
$2.88
$3.4461
52주 변동 폭
$1.35
$26.83
X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile
명칭
X 4 Pharmaceuticals Inc
전화
857-529-8300
주소
61 NORTH BEACON STREET, BOSTON, MA
XFOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XFOR
X 4 Pharmaceuticals Inc
|
3.17 | 72.74M | 32.77M | -101.98M | -112.43M | -9.6101 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-12 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2023-08-30 | 재개 | B. Riley Securities | Buy |
| 2022-12-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-12 | 개시 | Piper Sandler | Overweight |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2019-12-18 | 개시 | ROTH Capital | Buy |
| 2019-12-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-12-05 | 개시 | B. Riley FBR | Buy |
| 2019-06-07 | 개시 | Stifel | Buy |
| 2019-06-05 | 개시 | Cowen | Outperform |
모두보기
X 4 Pharmaceuticals Inc 주식(XFOR)의 최신 뉴스
Trading Recap: How much upside does X4 Pharmaceuticals Inc. haveMarket Risk Summary & Technical Pattern Alert System - khodrobank.com
What indicators show strength in X4 Pharmaceuticals Inc.Market Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
Detecting support and resistance levels for X4 Pharmaceuticals Inc.July 2025 Opening Moves & Community Consensus Stock Picks - newser.com
Is X4 Pharmaceuticals Inc. meeting your algorithmic filter criteriaIPO Watch & Entry Point Strategy Guides - newser.com
Is a relief rally coming for X4 Pharmaceuticals Inc. holdersCEO Change & Low Risk High Win Rate Stock Picks - newser.com
How to forecast X4 Pharmaceuticals Inc. trends using time seriesJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
What MACD signals say about X4 Pharmaceuticals Inc.Portfolio Profit Report & High Conviction Buy Zone Alerts - newser.com
Understanding X4 Pharmaceuticals Inc.’s price movementChart Signals & Long-Term Investment Growth Plans - newser.com
Technical analysis overview for X4 Pharmaceuticals Inc. stockWeekly Stock Summary & Daily Stock Trend Reports - newser.com
Portfolio Update: Is X4 Pharmaceuticals Inc forming a bullish divergenceQuarterly Trade Summary & Real-Time Buy Zone Alerts - khodrobank.com
Heatmap analysis for X4 Pharmaceuticals Inc. and competitorsDay Trade & Verified Entry Point Detection - newser.com
How to monitor X4 Pharmaceuticals Inc. with trend dashboards2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
Portfolio Recap: Does X4 Pharmaceuticals Inc outperform in volatile marketsJuly 2025 PreEarnings & Weekly High Conviction Ideas - khodrobank.com
Chart based exit strategy for X4 Pharmaceuticals Inc.July 2025 Final Week & Fast Gain Stock Tips - newser.com
Is X4 Pharmaceuticals Inc. stock reversal real or fakeInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
X4 Pharmaceuticals Announces Restructuring of Business Operations - MarketScreener
X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation - MarketScreener
50% Workforce Cut: X4 Pharmaceuticals Restructures Operations for $13M Savings, Reshapes Leadership - Stock Titan
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Short Interest Down 37.2% in August - Defense World
Earnings Risk: Whats the beta of X4 Pharmaceuticals Inc stockOil Prices & Comprehensive Market Scan Insights - khodrobank.com
Breakouts Watch: Is X4 Pharmaceuticals Inc stock a value trapJuly 2025 Update & Accurate Intraday Trade Tips - خودرو بانک
Can X4 Pharmaceuticals Inc navigate macro headwindsJuly 2025 Highlights & AI Forecasted Stock Moves - khodrobank.com
Growth Report: Is X4 Pharmaceuticals Inc. stock a value trap2025 Earnings Surprises & Stock Timing and Entry Methods - khodrobank.com
Weekly Earnings: What is X4 Pharmaceuticals Inc. s P E ratio telling usMarket Performance Summary & AI Based Trade Execution Alerts - خودرو بانک
Using Ichimoku Cloud for X4 Pharmaceuticals Inc. technicalsPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com
Merger Talk: What is the long term forecast for X4 Pharmaceuticals Inc stockGDP Growth & Safe Entry Momentum Tips - khodrobank.com
Analyst Downgrade: Will X4 Pharmaceuticals Inc benefit from sector rotationEntry Point & Reliable Intraday Trade Alerts - خودرو بانک
What’s the recovery path for long term holders of X4 Pharmaceuticals Inc.GDP Growth & Stepwise Trade Execution Plans - newser.com
How to escape a deep drawdown in X4 Pharmaceuticals Inc.2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
Weekly Recap: Can X4 Pharmaceuticals Inc sustain its profitabilityJuly 2025 Rallies & Low Volatility Stock Recommendations - خودرو بانک
Hedge Fund Bets: Will X4 Pharmaceuticals Inc stock go up in YEARJuly 2025 Trends & AI Driven Stock Reports - khodrobank.com
New Highs: What analysts say about X4 Pharmaceuticals Inc stockTrade Volume Report & Risk Managed Investment Signals - khodrobank.com
Market Leaders: What is X4 Pharmaceuticals Inc. s P E ratio telling usLayoff News & Daily Oversold Stock Bounce Ideas - khodrobank.com
Price action breakdown for X4 Pharmaceuticals Inc.Short Setup & Low Drawdown Momentum Ideas - newser.com
Comparing X4 Pharmaceuticals Inc. in custom built stock radarsJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Chart overlay techniques for tracking X4 Pharmaceuticals Inc.Earnings Performance Report & Weekly Momentum Stock Picks - newser.com
X 4 Pharmaceuticals Inc (XFOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
X 4 Pharmaceuticals Inc 주식 (XFOR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Baldry Mark | Chief Commercial Officer |
Nov 15 '24 |
Buy |
0.34 |
13,404 |
4,598 |
129,173 |
| Ragan Paula | President and CEO |
Jan 24 '25 |
Sale |
0.45 |
76,473 |
34,719 |
1,087,386 |
| Mostafa Adam S. | Chief Financial Officer |
Jan 24 '25 |
Sale |
0.45 |
74,773 |
33,947 |
0 |
| Baldry Mark | Chief Commercial Officer |
Jan 24 '25 |
Sale |
0.45 |
29,159 |
13,241 |
94,123 |
| DiBiase Mary | Chief Operating Officer |
Jan 24 '25 |
Sale |
0.45 |
22,258 |
10,094 |
490,980 |
| Arbet-Engels Christophe | Chief Medical Officer |
Jan 24 '25 |
Sale |
0.45 |
11,624 |
5,284 |
14,207 |
1.43%
0.09%
자본화:
|
볼륨(24시간):